Osteoarthritis Therapeutics Market Size to Worth Around USD 12.5 Million by 2027
The report analyzes and forecasts the Osteoarthritis Therapeutics Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Osteoarthritis Therapeutics Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Osteoarthritis Therapeutics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Osteoarthritis Therapeutics Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2426
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.
Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The players profiled in the report include Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Novartis AG, Pfizer Inc., Sanofi S.A., and others.
The major market segments of Osteoarthritis Therapeutics Market are as below:
Market By Drug Type
Viscosupplementation Agents
Nonsteroidal Anti-inflammatory Drugs
- Naproxen
- Aspirin
- Diclofenac
- Ibuprofen
- Other NSAIDs
Analgesics
- Duloxetine
- Acetaminophen
Corticosteroids
Market By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis
Market By Route of Administration
Parenteral Route
Topical Route
Oral Route
Market By Purchasing Pattern
Prescription Drugs
Over-the-Counter Drugs
Market By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Osteoarthritis Therapeutics
1.1. Definition and Scope
1.1.1. Definition of Osteoarthritis Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Osteoarthritis Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Osteoarthritis Therapeutics Market By Drug Type
1.2.3. Osteoarthritis Therapeutics Market By Anatomy
1.2.4. Osteoarthritis Therapeutics Market By Route of Administration
1.2.5. Osteoarthritis Therapeutics Market By Purchasing Pattern
1.2.6. Osteoarthritis Therapeutics Market By Distribution Channel
1.2.7. Osteoarthritis Therapeutics Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Cost Structure Analysis
3.5.1. Price Trend of Key Raw Materials
3.5.2. Raw Material Suppliers
3.5.3. Proportion of Manufacturing Cost Structure
3.5.3.1. Raw Material
3.5.3.2. Labor Cost
3.5.3.3. Manufacturing Expense
3.6. Regulatory Compliance
3.7. Competitive Landscape, 2019
3.7.1. Player Positioning Analysis
3.7.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Osteoarthritis Therapeutics Market By Drug Type
4.1. Introduction
4.2. Osteoarthritis Therapeutics Revenue By Drug Type
4.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast, By Drug Type, 2016-2027
4.2.2. Viscosupplementation Agents
4.2.2.1. Viscosupplementation Agents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Nonsteroidal Anti-inflammatory Drugs
4.2.3.1. Nonsteroidal Anti-inflammatory Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.1. Naproxen
4.2.3.1.1.1. Naproxen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.2. Aspirin
4.2.3.1.2.1. Aspirin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.3. Diclofenac
4.2.3.1.3.1. Diclofenac Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.4. Ibuprofen
4.2.3.1.4.1. Ibuprofen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.5. Other NSAIDs
4.2.3.1.5.1. Other NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Analgesics
4.2.4.1. Analgesics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.1.1. Duloxetine
4.2.4.1.1.1. Duloxetine Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.1.2. Acetaminophen
4.2.4.1.2.1. Acetaminophen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Corticosteroids
4.2.5.1. Corticosteroids Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Osteoarthritis Therapeutics Market Revenue By Anatomy
5.1. Introduction
5.2. Osteoarthritis Therapeutics Revenue (US$ Mn) By Anatomy
5.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
5.2.2. Knee Osteoarthritis
5.2.2.1. Knee Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Hip Osteoarthritis
5.2.3.1. Hip Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Hand Osteoarthritis
5.2.4.1. Hand Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Small Joint Osteoarthritis
5.2.5.1. Small Joint Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Osteoarthritis Therapeutics Market By Route of Administration
6.1. Introduction
6.2. Osteoarthritis Therapeutics Revenue (US$ Mn) By Route of Administration
6.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
6.2.2. Parenteral Route
6.2.2.1. Parenteral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Topical Route
6.2.3.1. Topical Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Oral Route
6.2.4.1. Oral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Osteoarthritis Therapeutics Market By Purchasing Pattern
7.1. Introduction
7.2. Osteoarthritis Therapeutics Revenue (US$) By Purchasing Pattern
7.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
7.3. Prescription Drugs
7.3.1. Prescription Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Over-the-Counter Drugs
7.4.1. Over-the-Counter Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. Osteoarthritis Therapeutics Market By Distribution Channel
8.1. Introduction
8.2. Osteoarthritis Therapeutics Revenue (US$) By Distribution Channel
8.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
8.3. Hospital Pharmacies
8.3.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.4. Retail Pharmacies
8.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.5. Online Pharmacies
8.5.1. Online Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 9. North America Osteoarthritis Therapeutics Market By Country
9.1. North America Osteoarthritis Therapeutics Overview
9.2. U.S.
9.2.1. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.2.2. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
9.2.3. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.2.4. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
9.2.5. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Canada
9.3.1. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.3.2. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
9.3.3. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.3.4. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
9.3.5. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. North America PEST Analysis
CHAPTER 10. Europe Osteoarthritis Therapeutics Market By Country
10.1. Europe Osteoarthritis Therapeutics Market Overview
10.2. U.K.
10.2.1. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.2.2. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.2.3. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.2.4. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.2.5. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.3. Germany
10.3.1. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.3.2. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.3.3. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.3.4. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.3.5. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.4. France
10.4.1. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.4.2. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.4.3. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.4.4. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.4.5. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.5. Spain
10.5.1. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.5.2. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.5.3. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.5.4. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.5.5. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.6. Rest of Europe
10.6.1. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.6.2. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.6.3. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.6.4. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.6.5. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Osteoarthritis Therapeutics Market By Country
11.1. Asia Pacific Osteoarthritis Therapeutics Market Overview
11.2. China
11.2.1. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.2.2. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
11.2.3. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.2.4. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
11.2.5. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.3. Japan
11.3.1. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.3.2. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
11.3.3. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.3.4. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
11.3.5. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4. India
11.4.1. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.4.2. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
11.4.3. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.4.4. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
11.4.5. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.5. Australia
11.5.1. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.5.2. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
11.5.3. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.5.4. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
11.5.5. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.6. South Korea
11.6.1. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.6.2. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
11.6.3. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.6.4. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
11.6.5. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.7.2. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
11.7.3. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.7.4. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
11.7.5. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Osteoarthritis Therapeutics Market By Country
12.1. Latin America Osteoarthritis Therapeutics Market Overview
12.2. Brazil
12.2.1. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
12.2.2. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
12.2.3. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
12.2.4. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
12.2.5. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.3. Mexico
12.3.1. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
12.3.2. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
12.3.3. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
12.3.4. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
12.3.5. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.4. Rest of Latin America
12.4.1. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
12.4.2. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
12.4.3. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
12.4.4. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
12.4.5. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 13. Middle East & Africa Osteoarthritis Therapeutics Market By Country
13.1. Middle East & Africa Osteoarthritis Therapeutics Market Overview
13.2. Saudi Arabia
13.2.1. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
13.2.2. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
13.2.3. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
13.2.4. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
13.2.5. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.3. UAE
13.3.1. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
13.3.2. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
13.3.3. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
13.3.4. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
13.3.5. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
13.4.2. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 – 2027
13.4.3. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
13.4.4. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 – 2027
13.4.5. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 14. Player Analysis Of Osteoarthritis Therapeutics
14.1. Osteoarthritis Therapeutics Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Osteoarthritis Therapeutics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Abbott Laboratories
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Mn), 2019
15.1.3.2. Abbott Laboratories 2019 Osteoarthritis Therapeutics Business Regional Distribution
15.1.4. Product/ Service and Specification
15.1.5. Recent Developments & Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. Anika Therapeutics Inc.
15.3. Bayer Aktiengesellschaft
15.4. Eli Lilly Company
15.5. Flexion Therapeutics Inc.
15.6. GlaxoSmithKline Plc
15.7. Horizon Therapeutics Plc
15.8. Johnson & Johnson Inc.
15.9. Novartis AG
15.10. Pfizer Inc.
15.11. Sanofi S.A
15.12. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2426
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
